, Curr Opin Immunol, vol.33, pp.101-111

A. Burocchi, M. P. Colombo, and S. Piconese, Convergences and divergences of thymusand peripherally derived regulatory T cells in cancer, Front Immunol, vol.4, p.247, 2013.

K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig et al., Inducing and expanding regulatory T cell populations by foreign antigen, Nat Immunol, vol.6, issue.12, pp.1219-1227, 2005.

J. M. Weiss, A. M. Bilate, M. Gobert, Y. Ding, C. De-lafaille et al., Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells, J Exp Med, vol.209, issue.10, pp.1723-1742, 1721.

G. Zhou and H. I. Levitsky, Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance, J Immunol, vol.178, issue.4, pp.2155-2162, 2007.

E. L. Pearce, M. C. Poffenberger, C. H. Chang, and R. G. Jones, Fueling immunity: insights into metabolism and lymphocyte function, Science, vol.342, p.1242454, 2013.

L. Berod, C. Friedrich, A. Nandan, J. Freitag, S. Hagemann et al., De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells, Nat Med, vol.20, issue.11, pp.1327-1333, 2014.

R. D. Michalek, V. A. Gerriets, S. R. Jacobs, A. N. Macintyre, N. J. Maciver et al., Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets, J Immunol, vol.186, issue.6, pp.3299-3303, 2011.

L. Z. Shi, R. Wang, G. Huang, P. Vogel, N. G. Green et al., HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells, J Exp Med, vol.208, issue.7, pp.1367-1376, 2011.

V. A. Gerriets, R. J. Kishton, A. G. Nichols, A. N. Macintyre, M. Inoue et al., Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation, J Clin Invest, vol.125, issue.1, pp.194-207, 2015.

D. Rosa, V. Galgani, M. Porcellini, A. Colamatteo, A. Santopaolo et al., Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants, Nat Immunol, vol.16, issue.11, pp.1174-1184, 2015.

V. A. Gerriets, R. J. Kishton, J. Mo, S. Cohen, P. J. Siska et al., Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression, Nat Immunol, vol.17, issue.12, pp.1459-1466, 2016.

C. Procaccini, D. Rosa, V. Galgani, M. Abanni, L. Cali et al., An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness, Immunity, vol.33, issue.6, pp.929-941, 2010.

C. Procaccini, F. Carbone, D. Silvestre, D. Brambilla, F. et al., The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements, Immunity, vol.44, issue.2, pp.406-421, 2016.

H. Zeng, K. Yang, C. Cloer, G. Neale, P. Vogel et al., ) mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function, Nature, vol.499, issue.7459, pp.485-490, 2013.

D. O'sullivan, G. J. Van-der-windt, S. C. Huang, J. D. Curtis, C. H. Chang et al., Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development, Immunity, vol.41, issue.1, pp.75-88, 2014.

P. C. Ho, J. D. Bihuniak, A. N. Macintyre, M. Staron, X. Liu et al., Phosphoenolpyruvate Is a Metabolic Checkpoint of Antitumor T Cell Responses, Cell, vol.162, issue.6, pp.1217-1228, 2015.

C. H. Chang, J. Qiu, D. O'sullivan, M. D. Buck, T. Noguchi et al., Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression, Cell, vol.162, issue.6, pp.1229-1241, 2015.

D. Cipolletta, M. Feuerer, A. Li, N. Kamei, J. Lee et al., PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells, Nature, vol.486, issue.7404, pp.549-553, 2012.

S. Piconese, P. Pittoni, A. Burocchi, A. Gorzanelli, A. Care et al., A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2, Eur J Immunol, vol.40, issue.10, pp.2902-2913, 2010.

S. Piconese, E. Timperi, I. Pacella, V. Schinzari, C. Tripodo et al., Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue, Hepatology, vol.60, issue.5, pp.1494-1507, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01149024

E. Timperi, I. Pacella, V. Schinzari, C. Focaccetti, L. Sacco et al., , 2016.

, Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer, Oncoimmunology, vol.5, issue.7, p.1175800

T. H. Mauad, C. M. Van-nieuwkerk, K. P. Dingemans, J. J. Smit, A. H. Schinkel et al., Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis, Am J Pathol, vol.145, issue.5, pp.1237-1245, 1994.

H. Lerat, M. Honda, M. R. Beard, K. Loesch, J. Sun et al., Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus, Gastroenterology, vol.122, issue.2, pp.352-365, 2002.

C. E. Ruby, M. A. Yates, D. Hirschhorn-cymerman, P. Chlebeck, J. D. Wolchok et al., Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right, J Immunol, vol.183, issue.8, pp.4853-4857, 2009.

A. M. Thornton, E. E. Donovan, C. A. Piccirillo, and E. M. Shevach, Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function, J Immunol, vol.172, issue.11, pp.6519-6523, 2004.

M. J. Turk, J. A. Guevara-patino, G. A. Rizzuto, M. E. Engelhorn, S. Sakaguchi et al., Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells, J Exp Med, vol.200, issue.6, pp.771-782, 2004.

A. N. Macintyre, V. A. Gerriets, A. G. Nichols, R. D. Michalek, M. C. Rudolph et al., The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function, Cell Metab, vol.20, issue.1, pp.61-72, 2014.

D. Simone, M. Arrigoni, A. Rossetti, G. Gruarin, P. Ranzani et al., Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells, vol.45, pp.1135-1147, 2016.

G. Plitas, C. Konopacki, K. Wu, P. D. Bos, M. Morrow et al., Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer. Immunity, vol.45, issue.5, pp.1122-1134, 2016.

K. Attridge and L. S. Walker, Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs, Immunol Rev, vol.259, issue.1, pp.23-39, 2014.

F. Carbone, D. Rosa, V. Carrieri, P. B. Montella, S. Bruzzese et al., Regulatory T cell proliferative potential is impaired in human autoimmune disease, Nat Med, vol.20, issue.1, pp.69-74, 2014.

A. Angelin, L. Gil-de-gomez, S. Dahiya, J. Jiao, L. Guo et al., Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments, Cell Metab, vol.25, issue.6, pp.1282-1293, 2017.

E. Mcdonnell, S. B. Crown, D. B. Fox, B. Kitir, O. R. Ilkayeva et al., Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation, Cell Rep, vol.17, issue.6, pp.1463-1472, 2016.

N. Arpaia, C. Campbell, X. Fan, S. Dikiy, J. Van-der-veeken et al., Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation, & Rudensky AY, vol.504, issue.7480, pp.451-455, 2013.

Y. Furusawa, Y. Obata, S. Fukuda, T. A. Endo, G. Nakato et al., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells, Nature, vol.504, issue.7480, pp.446-450, 2013.

J. Van-loosdregt and P. J. Coffer, Post-translational modification networks regulating FOXP3 function, Trends Immunol, vol.35, issue.8, pp.368-378, 2014.

Y. Kidani, H. Elsaesser, M. B. Hock, L. Vergnes, K. J. Williams et al., Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity, Nat Immunol, vol.14, issue.5, pp.489-499, 2013.

W. Yang, Y. Bai, Y. Xiong, J. Zhang, S. Chen et al., Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism, Nature, vol.531, issue.7596, pp.651-655, 2016.

S. Piconese, B. Valzasina, and M. P. Colombo, OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection, J Exp Med, vol.205, issue.4, pp.825-839, 2008.

X. Xiao, S. Balasubramanian, W. Liu, X. Chu, H. Wang et al., OX40 signaling favors the induction of T(H)9 cells and airway inflammation, Nat Immunol, vol.13, issue.10, pp.981-990, 2012.

E. L. Pearce, M. C. Walsh, P. J. Cejas, G. M. Harms, H. Shen et al., Enhancing CD8 T-cell memory by modulating fatty acid metabolism, Nature, vol.460, issue.7251, pp.103-107, 2009.

M. Ahmadian, J. M. Suh, N. Hah, C. Liddle, A. R. Atkins et al., PPARgamma signaling and metabolism: the good, the bad and the future, Nat Med, vol.19, issue.5, pp.557-566, 2013.

S. J. Bensinger and P. Tontonoz, Integration of metabolism and inflammation by lipidactivated nuclear receptors, Nature, vol.454, issue.7203, pp.470-477, 2008.

G. Donninelli, D. Cornò, M. Pierdominici, M. Scazzocchio, B. Varì et al., Distinct Blood and Visceral Adipose Tissue Regulatory T Cell and Innate Lymphocyte Profiles Characterize Obesity and Colorectal Cancer, Front Immunol, vol.8, p.643, 2017.

F. Rohrig and A. Schulze, The multifaceted roles of fatty acid synthesis in cancer, Nat Rev Cancer, vol.16, issue.11, pp.732-749, 2016.